LRCX Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
5.8B
+9.3%
5.3B
+0.4%
5.3B
+3.0%
5.2B
+9.6%
4.7B
Cost of Revenue
2.9B
+8.8%
2.7B
+2.1%
2.6B
+2.2%
2.6B
+7.3%
2.4B
Gross Profit
2.9B
+9.8%
2.7B
-1.3%
2.7B
+3.7%
2.6B
+11.9%
2.3B
Operating Expenses
863.5M
+2.7%
841.0M
-1.7%
855.8M
+0.8%
848.6M
+12.9%
751.9M
R&D
583.2M
+1.7%
573.3M
-0.5%
576.4M
-0.6%
580.2M
+10.3%
525.9M
SG&A
280.3M
+4.7%
267.7M
-4.2%
279.3M
+4.1%
268.4M
+18.8%
226.0M
Operating Income
2.0B
+13.1%
1.8B
-1.0%
1.8B
+5.1%
1.7B
+11.5%
1.6B
EBITDA
2.2B
+13.0%
1.9B
-0.9%
1.9B
+5.0%
1.8B
+10.9%
1.7B
Net Income
1.8B
+14.5%
1.6B
+1.6%
1.6B
-8.8%
1.7B
+29.3%
1.3B
EPS (Basic)
$1.46
+15.0%
$1.27
+2.4%
$1.24
-8.1%
$1.35
+29.8%
$1.04
EPS (Diluted)
$1.45
+15.1%
$1.26
+1.6%
$1.24
-8.1%
$1.35
+31.1%
$1.03
Shares (Diluted)
1.3B
-0.3%
1.3B
-0.6%
1.3B
-0.6%
1.3B
-0.9%
1.3B
Lam Research (LRCX) โ€” Financials